Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 10/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL204518 | 0.96 | CYP3A4 (0.47) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL9980309 | 0.96 | CYP3A4 (0.47) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL203107 | 0.87 | CYP3A4 (0.54) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL2710848 | 0.87 | CYP3A4 (0.54) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL2757500 | 0.87 | CYP3A4 (0.54) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL17644210 | 0.87 | PRCP (0.47) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL27978753 | 0.85 | PRCP (0.46) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL15368504 | 0.85 | CYP2C9 (0.49) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL27978669 | 0.85 | PRCP (0.44) | PRCPCYP3A4CYP2C9NR1I2KCNH2 | |
| SCHEMBL2709400 | 0.85 | PRCP (0.54) | PRCPCYP3A4CYP2C9NR1I2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626716-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| EP-3309157-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-3002281-B1 | ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC (US) | 2017-09-13 | — | — | EP | disclosed |
| EP-3002281-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2016-04-06 | — | — | EP | disclosed |